Director Dr. Craig Heller, PhD, leads the Stanford Center for Down Syndrome Research in a new and expanded collaborative effort between researchers and clinicians who study Down syndrome and related disorders. Our top priority is to evaluate in the clinic discoveries made with animal models of Down syndrome in order to improve the health and well-being of individuals with Down syndrome. Our mission is clear and simple: create a vibrant interdisciplinary team focused on improving learning, communication and independence among individuals with Down syndrome.
The primary goals of the Stanford Center for Down Syndrome Research are:
- Promote clinical and basic research programs to understand the underlying causes of learning deficits and communication disabilities in Down syndrome.
- Develop pharmaceutical and behavioral therapies for individuals with neurodevelopmental and neurodegenerative deficits.
- Offer clinical programs for Down syndrome individuals and their families.
- Plan and execute clinical trials of promising therapies that can improve the lives of individuals with Down syndrome and their families.